Luís Puga

Dr. Luís Puga

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBManuel Barreiro-Pérez
Manuel Barreiro-Pérez
BCBerenice Caneiro-Queija
Berenice Caneiro-Queija
LPLuís Puga
Luís Puga
RGRocío Gonzalez-Ferreiro
Rocío Gonzalez-Ferreiro
RCRobert Alarcón Cedeño
Robert Alarcón Cedeño
RERodrigo Estévez-Loureiro
Rodrigo Estévez-Loureiro
Mitral regurgitation is the second-most frequent valvular heart disease in Europe and it is associated with high morbidity and mortality. Recognition of MR should encourage the assessment of its etiology, severity, and mechanism in order to determine the best therapeutic approach. Mitral valve surgery constitutes the first-line therapy; however, transcatheter procedures have emerged as an alternative option to treat inoperable and high-risk surgical patients. In patients with suitable anatomy, the transcatheter edge-to-edge mitral leaflet repair is the most frequently applied procedure. In non-reparable patients, transcatheter mitral valve replacement (TMVR) has appeared as a promising intervention. Thus, currently TMVR represents a new treatment option for inoperable or high-risk patients with degenerated or failed bioprosthetic valves (valve-in-valve); failed repairs, (valve-in-ring); inoperable or high-risk patients with native mitral valve anatomy, or those with severe annular calcifications, or valve-in-mitral annular calcification. The patient selection requires multimodality imaging pre-procedural planning to select the best approach and device, study the anatomical landing zone and assess the risk of left ventricular outflow tract obstruction. In the present review, we aimed to highlight the main considerations for TMVR planning from an imaging perspective; before, during, and after TMVR.

9 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBManuel Barreiro-Pérez
Manuel Barreiro-Pérez
RGRocío González-Ferreiro
Rocío González-Ferreiro
BCBerenice Caneiro-Queija
Berenice Caneiro-Queija
MTMarta Tavares-Silva
Marta Tavares-Silva
LPLuís Puga
Luís Puga
AIAndres Iniguez-Romo
Andres Iniguez-Romo
Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic.

1 January 2018 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDPaulo Gomes Dinis
Paulo Gomes Dinis
RTRogério Teixeira
Rogério Teixeira
LPLuís Puga
Luís Puga
CLCarolina Lourenço
Carolina Lourenço
MCMaria Carmo Cachulo
Maria Carmo Cachulo
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves

2 June 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
PSPedro A Sousa
Pedro A Sousa
SBSérgio Barra
Sérgio Barra
CSCarolina Saleiro
Carolina Saleiro
ZKZiad Khoueiry
Ziad Khoueiry
LALuís Adão
Luís Adão
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves
Pulmonary vein isolation (PVI) guided by the Ablation Index (AI) has shown high acute and mid-term efficacy in the treatment of paroxysmal atrial fibrillation (AF). Previous data before the AI-era had suggested that wide-area circumferential ablation (WACA) was preferable to ostial ablation. However, with the use of AI, we hypothesize that ostial circumferential ablation is non-inferior to WACA and can improve outcomes in paroxysmal AF. Prospective, multicentre, non-randomized, non-inferiority study of consecutive patients were referred for paroxysmal AF ablation from January 2020 to September 2021. All procedures were performed using the AI software, and patients were separated into two different groups: WACA vs. ostial circumferential ablation. Acute reconnection, procedural data, and 1-year arrhythmia recurrence were assessed. During the enrolment period, 162 patients (64% males, mean age of 60 ± 11 years) fulfilled the study inclusion criteria—81 patients [304 pulmonary vein (PV)] in the WACA group and 81 patients (301 PV) in the ostial group. Acute PV reconnection was identified in 7.9% [95% confidence interval (CI), 4.9–11.1%] of PVs in the WACA group compared with 3.3% (95% CI, 1.8–6.1%) of PVs in the ostial group [P < 0.001 for non-inferiority; adjusted odds ratio 0.51 (95% CI, 0.23–0.83), P = 0.05]. Patients in the WACA group had longer ablation (35 vs. 29 min, P = 0.001) and procedure (121 vs. 102 min, P < 0.001) times. No significant difference in arrhythmia recurrence was seen at 1-year of follow-up [11.1% in WACA vs. 9.9% in ostial, hazard ratio 1.13 (95% CI, 0.44–1.94), P = 0.80 for superiority]. In paroxysmal AF patients treated with tailored AI-guided PVI, ostial circumferential ablation is not inferior to WACA with regard to acute PV reconnection, while allowing quicker procedures with less ablation time. Distribution of acute pulmonary vein reconnection in both groups [wide-area circumferential ablation (WACA) vs. ostial] (central panel), with an illustration of the typical location for ablation lines in each corresponding group, in a posterior view (left panel). Ostial ablation was not inferior to WACA with regard to acute pulmonary vein reconnections (P < 0.001 for non-inferiority; P = 0.05 adjusted for superiority) and arrhythmia recurrence at 1-year of follow-up (P < 0.001 for non-inferiority; P = 0.80 for superiority), while requiring less ablation (P = 0.001) and allowing for quicker procedures (P < 0.001) (right panel).

14 June 2022 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PSPedro A. Sousa
Pedro A. Sousa
SBSérgio Barra
Sérgio Barra
LALuís Adão
Luís Adão
JPJoão Primo
João Primo
ZKZiad Khoueiry
Ziad Khoueiry
SMStudy Group Members
Study Group Members

17 August 2022 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MBManuel Barreiro-Pérez
Manuel Barreiro-Pérez
RERodrigo Estevez-Loureiro
Rodrigo Estevez-Loureiro
JBJose Antonio Baz
Jose Antonio Baz
MPMiguel A. Piñón
Miguel A. Piñón
FMFrancesco Maisano
Francesco Maisano
AIAndres Iñiguez-Romo
Andres Iñiguez-Romo